Topics
endocrine disruptor
February 7, 2018
Experts on pediatrics and public health publish book on effects of ubiquitous chemical exposures on children’s health; focus on non-communicable diseases such as autism, ADHD, birth defects, cancer
Reading time: 1 minute
February 5, 2018
Industry groups say the latest decision to identify BPA as SVHC for endocrine disruption effects in the environment is ‘disproportionate’ and lacks regulatory value; ECHA comments that this entry will impact the scope of the authorization requirement
Reading time: 2 minutes
February 5, 2018
‘Real-world’ dietary intervention study highlights inadequate labeling as a barrier to following individual-focused strategies aimed at reduction of dietary BPA exposure
Reading time: 2 minutes
February 2, 2018
Responders to consultation on draft guidance for identification of EDCs criticize too high level of evidence required and too narrow scope
Reading time: 2 minutes
January 15, 2018
ECHA adds 7 new SVHCs to Candidate List; entry for BPA updated to include endocrine disrupting properties with effects on environment
Reading time: 1 minute
December 18, 2017
Op-ed by Swedish chemical scientists criticizes EU’s slow pace of regulating hazardous chemicals, highlights magnitude of health and environmental consequences
Reading time: 1 minute
December 15, 2017
EFSA publishes BPA hazard assessment protocol along with report on public consultation outcomes; collection of studies to start in 2018
Reading time: 1 minute
December 14, 2017
Member States vote in favor of EU Commission’s new proposal for criteria to identify endocrine disrupting pesticides; exemption for substances with intentional endocrine activity removed; NGOs criticize remaining high burden of proof
Reading time: 1 minute
December 13, 2017
PAN Europe criticizes draft guidance for identifying endocrine disruptors published by EFSA and ECHA; too much focus on mode of action of chemicals, precautionary principle overlooked, organization claims
Reading time: 1 minute
December 7, 2017
EFSA and ECHA publish draft guidance document on identification of endocrine disruptors; public consultation open until January 31, 2018
Reading time: 1 minute
